Advisors Asset Management, Inc. Omeros Corp Transaction History

Advisors Asset Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$9.57 - $21.32 $204,175 - $454,862	-21,335 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$12.21 - $16.99 $183 - $254	-15 Reduced 0.07%	21,335 $314,000
Q1 2020 May 15, 2020	SELL	$9.03 - $19.72 $6,609 - $14,435	-732 Reduced 3.31%	21,350 $285,000
Q4 2019 Feb 14, 2020	SELL	$13.01 - $17.15 $10,238 - $13,497	-787 Reduced 3.44%	22,082 $311,000
Q3 2019 Nov 14, 2019	SELL	$14.55 - $20.56 $17,343 - $24,507	-1,192 Reduced 4.95%	22,869 $373,000
Q2 2019 Aug 14, 2019	SELL	$15.0 - $19.62 $9,540 - $12,478	-636 Reduced 2.58%	24,061 $378,000
Q1 2019 May 15, 2019	SELL	$11.65 - $17.72 $2,621 - $3,986	-225 Reduced 0.9%	24,697 $429,000
Q4 2018 Jan 31, 2019	BUY	$10.72 - $16.73 $134,964 - $210,630	12,590 Added 102.09%	24,922 $278,000
Q3 2018 Nov 15, 2018	BUY	$17.73 - $26.69 $218,646 - $329,141	12,332 New	12,332 $301,000

152

28M

369K

697K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $197M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisors Asset Management, Inc. with notifications on news.